文献速递眼底病与葡萄膜炎

视网膜液体积自动定量评估作为新生血管性年龄相关性黄斑变性的重要生物标志物

Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration.
PubMed 文献 · Am J Ophthalmol · 2021-02-15

本文评估人工智能算法从OCT扫描中提取的视网膜液体积数据在新生血管性AMD治疗中的应用。研究汇总了临床试验(HARBOR)和真实世界多个中心的数据,显示液体积可用纳升(nL)量化,且抗VEGF治疗后液体积快速下降,不同人群基线液体积范围差异大。作者提出纳升作为统一单位,并探讨了这些定量指标在临床实践和研究中的优势。

要点

  • AI算法可从OCT高效提取视网膜内液、视网膜下液和色素上皮脱离体积。
  • 初治时液体积范围差异大,抗VEGF治疗后平均体积快速一致下降。
  • 建议使用纳升作为液体积的统一单位以便研究间比较。

核心结论

  • 视网膜内液、视网膜下液和色素上皮脱离的定量测量是新生血管性AMD的重要生物标志物。
  • 人工智能算法可从OCT扫描中高效提取准确体积,辅助渗出性黄斑疾病的治疗决策。
  • 自动液体积监测可识别不同新生血管性AMD人群在基线和随访期间的液体特征。

研究设计与样本

  • 本研究的設計為視角性綜述,回顧了來自不同臨床設置的視網膜影像數據集。
  • 數據集包括臨床試驗HARBOR(24,362次掃描,1,095眼)、AREDS2十年隨訪(511次掃描,511眼)、貝爾法斯特(4,673次掃描,880眼)和特拉維夫(1,470次掃描,132眼)真實世界中心。
  • 使用Vienna Fluid Monitor或Notal OCT Analyzer對黃斑立方掃描進行分析。

主要发现

  • 初治階段液體體積範圍差異大:視網膜內液0-3,435 nL,視網膜下液0-5,018 nL,色素上皮脫離0-10,022 nL。
  • 抗VEGF治療後平均液體體積快速且一致下降。
  • 維持治療期間,平均視網膜內液體積在特拉維夫最高(100 nL),貝爾法斯特和HARBOR-PRN較低,HARBOR-每月最低(21 nL)。
  • 平均視網膜下液體積在所有組中均較低:HARBOR-每月30 nL,其他組48-49 nL。

关键数值与推荐

  • 初治階段視網膜內液體積範圍0-3,435 nL。
  • 初治階段視網膜下液體積範圍0-5,018 nL。
  • 初治階段色素上皮脫離體積範圍0-10,022 nL。
  • 維持治療期間平均視網膜內液體積:特拉維夫100 nL,HARBOR-每月21 nL。
  • 維持治療期間平均視網膜下液體積:HARBOR-每月30 nL,其他組48-49 nL。

临床怎么用

  • AI自動定量OCT液體體積可高效提供視網膜內液、視網膜下液和色素上皮脫離的客觀指標,輔助新生血管性AMD的治療監測。
  • 建議臨床和研究中使用納升作為液體體積的統一單位,以促進研究間一致性。
  • 自動液體監測有助於識別不同人群在基線和隨訪中的液體特徵,指導個體化治療。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate retinal fluid volume data extracted from optical coherence tomography (OCT) scans by artificial intelligence algorithms in the treatment of neovascular age-related macular degeneration (NV-AMD). DESIGN: Perspective. METHODS: A review was performed of retinal image repository datasets from diverse clinical settings. SETTINGS: Clinical trial (HARBOR) and trial follow-on (Age-Related Eye Disease Study 2 10-year Follow-On); real-world (Belfast and Tel-Aviv tertiary centers). PATIENTS: 24,362 scans of 1,095 eyes (HARBOR); 4,673 of 880 (Belfast); 1,470 of 132 (Tel-Aviv); 511 of 511 (Age-Related Eye Disease Study 2 10-year Follow-On). ObservationProcedures: Vienna Fluid Monitor or Notal OCT Analyzer applied to macular cube scans. OutcomeMeasures: Intraretinal fluid (IRF), subretinal fluid (SRF), and pigment epithelial detachment (PED) volumes. RESULTS: The fluid volumes measured in neovascular AMD were expressed efficiently in nanoliters. Large ranges that differed by population were observed at the treatment-naïve stage: 0-3,435 nL (IRF), 0-5,018 nL (SRF), and 0-10,022 nL (PED). Mean volumes decreased rapidly and consistently with anti-vascular endothelial growth factor therapy. During maintenance therapy, mean IRF volumes were highest in Tel-Aviv (100 nL), lower in Belfast and HARBOR-Pro Re Nata, and lowest in HARBOR-monthly (21 nL). Mean SRF volumes were low in all: 30 nL (HARBOR-monthly) and 48-49 nL (others). CONCLUSIONS: Quantitative measures of IRF, SRF, and PED are important biomarkers in NV-AMD. Accurate volumes can be extracted efficiently from OCT scans by artificial intelligence algorithms to guide the treatment of exudative macular diseases. Automated fluid monitoring identifies fluid characteristics in different NV-AMD populations at baseline and during follow-up. For consistency between studies, we propose the nanoliter as a convenient unit. We explore the advantages of using these quantitative metrics in clinical practice and research.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Keenan TDL, Chakravarthy U, Loewenstein A, et al. Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2021. PMID: 33359681. doi:10.1016/j.ajo.2020.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。